Document detail
ID

doi:10.1186/s12889-023-17325-9...

Author
Liu, Yingjie Chu, Zhenxing Wang, Hongyi Huang, XiaoJie Chen, YaoKai Wang, Hui Zou, Dehua Jiang, YongJun Geng, WenQing Hu, Qinghai Zhou, Baosen Shang, Hong
Langue
en
Editor

BioMed Central

Category

Epidemiology

Year

2023

listing date

12/20/2023

Keywords
men who have sex with men hiv long-acting injectable pre-exposure prophylaxis willingness factor suboptimal croprep willing users willingness lai-prep ci [95% msm study = 0 prep fcps oral 0
Metrics

Abstract

Introduction Evidence on the willingness of men who have sex with men (MSM) with oral pre-exposure prophylaxis (PrEP) experience, especially those with suboptimal adherence, to take long-acting injectable PrEP (LAI-PrEP) is critical to guide future LAI-PrEP implementation.

Objective The objective was to assess the willingness of MSM with oral PrEP experience to take LAI-PrEP.

Methods MSM who participated in the China Real-world Study of Oral PrEP (CROPrEP) were enrolled in this study.

Information on the willingness of MSM to take LAI-PrEP and potential correlates was collected using a structured online questionnaire.

The main outcomes were the willingness of MSM to take LAI-PrEP and its association with HIV-related behaviours, sexually transmitted infections, and oral PrEP history.

Logistic regression was used to identify correlates of the willingness of MSM to take LAI-PrEP.

Results A total of 612 former CROPrEP participants (FCPs) were included in this study.

There were 315 (51.5%) daily oral PrEP (D-PrEP) users and 297 (48.5%) event-driven oral PrEP (ED-PrEP) users at the last follow-up.

Most FCPs (77.8%) were willing to take free LAI-PrEP.

FCPs with no less than two sexual male partners (aOR = 1.54, [95% CI: 1.04, 2.29], P  = 0.031), those with male partners with unknown HIV statuses (aOR = 2.04, [95% CI: 1.31, 3.18], P  = 0.002), those with recreational drug use (aOR = 1.58, [95% CI: 1.05, 2.40], P  = 0.030), and those with HSV-2 positivity (aOR = 2.15, [95% CI: 1.30, 3.57], P  = 0.003) were more willing to take LAI-PrEP, while ED-PrEP users (aOR = 0.66, [95% CI: 0.45, 0.98], P  = 0.037) and FCPs with suboptimal oral PrEP adherence (aOR = 0.58, [95% CI: 0.36, 0.94], P  = 0.026) were less willing to take LAI-PrEP.

Conclusion LAI-PrEP has good prospects for expanding PrEP coverage.

However, FCPs with suboptimal oral PrEP adherence are less likely to take LAI-PrEP.

Further intervention and implementation efforts are needed to improve the willingness of MSM to use LAI-PrEP, and sexual health should be considered during the discussion about PrEP initiation.

Liu, Yingjie,Chu, Zhenxing,Wang, Hongyi,Huang, XiaoJie,Chen, YaoKai,Wang, Hui,Zou, Dehua,Jiang, YongJun,Geng, WenQing,Hu, Qinghai,Zhou, Baosen,Shang, Hong, 2023, Willingness to take long-acting injectable pre-exposure prophylaxis among men who have sex with men who participated in the CROPrEP study: a cross-sectional online study, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI